FDA Adverse Event Injury Summary report: N

ENDURON 10D 60 OR 72ODX28ID

MDR report key: 3914182 · Received July 3, 2014

Report

Report Number
1818910-2014-22675
Event Type
Injury
Date Received
July 3, 2014
Date of Event
June 10, 2014
Report Date
June 10, 2014
Manufacturer
DEPUY ORTHOPAEDICS, INC.1818910
Product Code
LPH
PMA / PMN Number
PK944538
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Additional Manufacturer Narrative · 1

THE DEVICE ASSOCIATED WITH THIS REPORT WAS NOT RETURNED. A COMPLAINT DATABASE SEARCH FINDS NO OTHER REPORTED INCIDENTS AGAINST THE PROVIDED PRODUCT AND LOT COMBINATION. REQUESTS FOR ADDITIONAL INVESTIGATIONAL INPUTS WERE MADE IN ACCORDANCE WITH WI-7915 APPENDIX A. MEDICAL RECORDS AND X-RAY(S) WERE OBTAINED AND REVIEWED BY A MEDICAL PROFESSIONAL. IT CANNOT BE DETERMINED WITH THE LIMITED AMOUNT OF INFORMATION PROVIDED THAT THE COMPLAINT IS PRODUCT RELATED. THE INVESTIGATION COULD NOT VERIFY OR IDENTIFY ANY PRODUCT CONTRIBUTION TO THE REPORTED EVENT WITHOUT DEVICE EXAMINATION. THE PATIENT IS CONSIDERED OBESE. IT WOULD NOT BE UNREASONABLE TO FIND POLY MATERIAL WEAR AFTER THE LENGTH OF TIME REPORTED AS IMPLANTED. BASED ON THE INABILITY TO IDENTIFY ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION WAS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY.

Description of Event or Problem · 1

PATIENT WAS REVISED TO ADDRESS POLY WEAR.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
391699 ENDURON 10D 60 OR 72ODX28ID HIP ACETABULAR INSERT/LINER LPH DEPUY ORTHOPAEDICS, INC.1818910 V2XAEA052

Patients

Seq Age Sex Outcome Treatment
1 54 YR Required Intervention